Related references
Note: Only part of the references are listed.Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation-dependence on GPR120
Pei Liang et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2022)
Reduction-Sensitive Dextran-Paclitaxel Polymer-Drug Conjugate: Synthesis, Self-Assembly into Nanoparticles, and In Vitro Anticancer Efficacy
Sidra Kanwal et al.
BIOCONJUGATE CHEMISTRY (2021)
Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer
Hung-Wei Cheng et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Emerging nanotaxanes for cancer therapy
Yachao Zhang et al.
BIOMATERIALS (2021)
Recent advances in dextran-based drug delivery systems: From fabrication strategies to applications
Qiaobin Hu et al.
CARBOHYDRATE POLYMERS (2021)
Redox-responsive hyaluronic acid-based nanoparticles for targeted photodynamic therapy/chemotherapy against breast cancer
Rujuan Wang et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2021)
Docetaxel Skin Exposure and Micronucleation Contributes to Skin Toxicity Caused by CPC634
Florence Atrafi et al.
CANCERS (2021)
Preclinical Evaluation of a Cabazitaxel Prodrug Using Nanoparticle Delivery for the Treatment of Taxane-Resistant Malignancies
Binbin Xie et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with solvent-based taxanes for metastatic breast cancer: A meta-analysis
Hwaryeon Lee et al.
SCIENTIFIC REPORTS (2020)
n-3 Polyunsaturated Fatty Acid Amides: New Avenues in the Prevention and Treatment of Breast Cancer
Cinzia Giordano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Acid-responsive dextran-based therapeutic nanoplatforms for photodynamic-chemotherapy against multidrug resistance
Lin Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
EPA and DHA Fatty Acids Induce a Remodeling of Tumor Vasculature and Potentiate Docetaxel Activity
Caroline Goupille et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer
Ruben A. G. van Eerden et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Morphology tunable and acid-sensitive dextran-doxorubicin conjugate assemblies for targeted cancer therapy
Qingfei Zhang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer
Pei Liang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer
Pei Liang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates
Alexey E. Machulkin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts
Marnie Newell et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines
Ilya S. Senatorov et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Schiff base-containing dextran nanogel as pH-sensitive drug delivery system of doxorubicin: Synthesis and characterization
Hongying Su et al.
JOURNAL OF BIOMATERIALS APPLICATIONS (2018)
Induction of GPR40 positively regulates cell motile and growth activities in breast cancer MCF-7 cells
Kaori Fukushima et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2018)
Application of dextran as nanoscale drug carriers
Gangliang Huang et al.
NANOMEDICINE (2018)
Determination of the Relative Efficacy of Eicosapentaenoic Acid and Docosahexaenoic Acid for Anti-Cancer Effects in Human Breast Cancer Models
Laura VanderSluis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Paclitaxel: What has been done and the challenges remain ahead
Ezequiel Bernabeu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Carbohydrate-based amphiphilic nano delivery systems for cancer therapy
Kegang Liu et al.
NANOSCALE (2016)
Eicosopentaneoic Acid and Other Free Fatty Acid Receptor Agonists Inhibit Lysophosphatidic Acid- and Epidermal Growth Factor-Induced Proliferation of Human Breast Cancer Cells
Mandi M. Hopkins et al.
JOURNAL OF CLINICAL MEDICINE (2016)
A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models
Jayanta Bhattacharyya et al.
NATURE COMMUNICATIONS (2015)
Docosahexaenoic acid, G protein-coupled receptors, and melanoma: is G protein-coupled receptor 40 a potential therapeutic target?
Deepika Nehra et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma
Q. Wu et al.
ONCOGENE (2013)
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial
Mark A. Socinski et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Synthetic Modification of Carboxymethylcellulose and Use Thereof to Prepare a Nanoparticle Forming Conjugate of Docetaxel for Enhanced Cytotoxicity against Cancer Cells
Mark J. Ernsting et al.
BIOCONJUGATE CHEMISTRY (2011)
GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
Da Young Oh et al.
CELL (2010)
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma
Jade Homsi et al.
MELANOMA RESEARCH (2010)
The Use of Amino Acid Linkers in the Conjugation of Paclitaxel with Hyaluronic Acid as Drug Delivery System: Synthesis, Self-Assembled Property, Drug Release, and In Vitro Efficiency
Dingcheng Xin et al.
PHARMACEUTICAL RESEARCH (2010)
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, TaxoprexinA®, in resistant solid tumor malignancies
Paula M. Fracasso et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Heparin-Paclitaxel Conjugates Using Mixed Anhydride as Intermediate: Synthesis, Influence of Polymer Structure on Drug Release, Anticoagulant Activity and In Vitro Efficiency
Ying Wang et al.
PHARMACEUTICAL RESEARCH (2009)
Carrier effects on antitumor activity and neurotoxicity of AZ10992, a paclitaxel-carboxymethyl dextran conjugate, in a mouse model
Shu-ichi Sugahara et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Oleic acid induces ERK1/2 activation and AP-1 DNA binding activity through a mechanism involving Src kinase and EGFR transactivation in breast cancer cells
Adriana Soto-Guzman et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Complete regression of xenografted human carcinomas by a paclitaxel-carboxymethyl dextran conjugate (AZ10992)
Shu-ichi Sugahara et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40
S Hardy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens
JS Kloover et al.
BRITISH JOURNAL OF CANCER (2004)
Existence of GPR40 functioning in a human breast cancer cell line, MCF-7
T Yonezawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Paclitaxel delivery systems: The use of amino acid linkers in the conjugation of paclitaxel with carboxymethyldextran to create prodrugs
S Sugahara et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2002)
Carrier and dose effects on the pharmacokinetics of T-0128, a camtothecin analogue-carboxymethyl dextran conjugate, in non-tumor- and tumor-bearing rats
M Harada et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Share Paper
